Overview

Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration

Status:
ENROLLING_BY_INVITATION
Trial end date:
2026-07-05
Target enrollment:
Participant gender:
Summary
This Clinical Trial evaluates the nasal administration of Methylprednisolone as a treatment strategy for Acute Relapses in Multiple Sclerosis
Phase:
PHASE2
Details
Lead Sponsor:
Universidad Nacional Autonoma de Mexico
Collaborator:
Instituto Nacional de Neurología y Neurocirugía